pubmed-article:20347167 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20347167 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
pubmed-article:20347167 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
pubmed-article:20347167 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:20347167 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
pubmed-article:20347167 | lifeskim:mentions | umls-concept:C0278488 | lld:lifeskim |
pubmed-article:20347167 | lifeskim:mentions | umls-concept:C0006141 | lld:lifeskim |
pubmed-article:20347167 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:20347167 | pubmed:dateCreated | 2010-7-27 | lld:pubmed |
pubmed-article:20347167 | pubmed:abstractText | Local treatments seem to improve metastasis progression-free survival (MPFS) and overall survival (OS) when added to systemic therapies in stage IV breast cancer. | lld:pubmed |
pubmed-article:20347167 | pubmed:language | eng | lld:pubmed |
pubmed-article:20347167 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20347167 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20347167 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20347167 | pubmed:month | Aug | lld:pubmed |
pubmed-article:20347167 | pubmed:issn | 1879-0887 | lld:pubmed |
pubmed-article:20347167 | pubmed:author | pubmed-author:ArriagadaRodr... | lld:pubmed |
pubmed-article:20347167 | pubmed:author | pubmed-author:MathieuMarie-... | lld:pubmed |
pubmed-article:20347167 | pubmed:author | pubmed-author:MarsigliaHugo... | lld:pubmed |
pubmed-article:20347167 | pubmed:author | pubmed-author:DelalogeSuzet... | lld:pubmed |
pubmed-article:20347167 | pubmed:author | pubmed-author:DunantArianeA | lld:pubmed |
pubmed-article:20347167 | pubmed:author | pubmed-author:UzanCatherine... | lld:pubmed |
pubmed-article:20347167 | pubmed:author | pubmed-author:BalleyguierCo... | lld:pubmed |
pubmed-article:20347167 | pubmed:author | pubmed-author:BourgierCélin... | lld:pubmed |
pubmed-article:20347167 | pubmed:author | pubmed-author:KhodariWassim... | lld:pubmed |
pubmed-article:20347167 | pubmed:author | pubmed-author:VataireAnne-L... | lld:pubmed |
pubmed-article:20347167 | pubmed:author | pubmed-author:PessoaEduardo... | lld:pubmed |
pubmed-article:20347167 | pubmed:copyrightInfo | Copyright 2010 Elsevier Ireland Ltd. All rights reserved. | lld:pubmed |
pubmed-article:20347167 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20347167 | pubmed:volume | 96 | lld:pubmed |
pubmed-article:20347167 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20347167 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20347167 | pubmed:pagination | 199-203 | lld:pubmed |
pubmed-article:20347167 | pubmed:meshHeading | pubmed-meshheading:20347167... | lld:pubmed |
pubmed-article:20347167 | pubmed:meshHeading | pubmed-meshheading:20347167... | lld:pubmed |
pubmed-article:20347167 | pubmed:meshHeading | pubmed-meshheading:20347167... | lld:pubmed |
pubmed-article:20347167 | pubmed:meshHeading | pubmed-meshheading:20347167... | lld:pubmed |
pubmed-article:20347167 | pubmed:meshHeading | pubmed-meshheading:20347167... | lld:pubmed |
pubmed-article:20347167 | pubmed:meshHeading | pubmed-meshheading:20347167... | lld:pubmed |
pubmed-article:20347167 | pubmed:meshHeading | pubmed-meshheading:20347167... | lld:pubmed |
pubmed-article:20347167 | pubmed:meshHeading | pubmed-meshheading:20347167... | lld:pubmed |
pubmed-article:20347167 | pubmed:meshHeading | pubmed-meshheading:20347167... | lld:pubmed |
pubmed-article:20347167 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20347167 | pubmed:articleTitle | Breast radiotherapy as part of loco-regional treatments in stage IV breast cancer patients with oligometastatic disease. | lld:pubmed |
pubmed-article:20347167 | pubmed:affiliation | Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France. bourgier@igr.fr | lld:pubmed |
pubmed-article:20347167 | pubmed:publicationType | Journal Article | lld:pubmed |